FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 132 filers reported holding FLEXION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $750,000 | -18.1% | 72,072 | +3.4% | 0.05% | -18.8% |
| Q2 2020 | $916,000 | +62.7% | 69,711 | -2.6% | 0.06% | +52.4% |
| Q1 2020 | $563,000 | -55.7% | 71,575 | +16.5% | 0.04% | -44.0% |
| Q4 2019 | $1,272,000 | +53.6% | 61,449 | +1.6% | 0.08% | +47.1% |
| Q3 2019 | $828,000 | +4.5% | 60,475 | -6.2% | 0.05% | +2.0% |
| Q2 2019 | $792,000 | -21.0% | 64,448 | -19.8% | 0.05% | -21.9% |
| Q1 2019 | $1,002,000 | -4.7% | 80,348 | -13.5% | 0.06% | -11.1% |
| Q4 2018 | $1,051,000 | -41.4% | 92,877 | -3.2% | 0.07% | -31.4% |
| Q3 2018 | $1,795,000 | -36.3% | 95,965 | -12.0% | 0.10% | -23.9% |
| Q2 2018 | $2,817,000 | -2.5% | 109,003 | -15.5% | 0.14% | +2.2% |
| Q1 2018 | $2,889,000 | -9.2% | 128,924 | +1.4% | 0.14% | +3.8% |
| Q4 2017 | $3,182,000 | +6.2% | 127,104 | +2.6% | 0.13% | +2.4% |
| Q3 2017 | $2,996,000 | – | 123,904 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |